62.1 Participant assessment of success by analysing scores and scales |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.1.1 4 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.1.2 10 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.1.3 16 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.2 Physician assessment of success by analysing scores and scales |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.2.1 4 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.2.2 16 weeks |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |
62.3 Total adverse events |
1 |
|
Risk Ratio (M‐H, Random, 95% CI) |
Totals not selected |